Sagimet Biosciences Inc.
SGMT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$46 | -$28 | -$30 | -$24 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $5 | $2 | $2 |
| Change in WC | -$1 | -$1 | $4 | -$0 |
| Other Non-Cash | -$1 | $0 | -$0 | $1 |
| Operating Cash Flow | -$42 | -$24 | -$24 | -$22 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$108 | -$20 | -$41 | $0 |
| Inv. Sales/Matur. | $46 | $32 | $9 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$62 | $13 | -$32 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $106 | $90 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1 | -$4 | -$0 | $10 |
| Financing Cash Flow | $105 | $86 | -$0 | $10 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | $75 | -$57 | -$12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75 | $0 | $57 | $69 |
| End Cash | $76 | $75 | $0 | $57 |
| Free Cash Flow | -$42 | -$24 | -$24 | -$22 |